Join to View Full Profile
333 Cottman AveFox Chase Cancer CenterPhiladelphia, PA 19111
Phone+1 215-728-6900
Fax+1 215-214-1425
Dr. Treat is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
MedStart Georgetown University HospitalFellowship, Medical Oncology, 1984
MedStar Health Georgetown University/Georgetown HospitalResidency, Internal Medicine, 1979 - 1982
Lewis Katz School of Medicine at Temple UniversityClass of 1979
Certifications & Licensure
PA State Medical License 1988 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC Start of enrollment: 2019 Sep 04
Publications & Presentations
PubMed
- 1 citationsPhase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatm...J Nicholas Bodor, Jonathan Dowell, Joseph Treat, Janakiraman Subramanian, Nihal Abdulla
Clinical Lung Cancer. 2025-09-01 - Brief Report: The Immune Profiles of the Molecular Subtypes of EGFR-Mutant Lung Adenocarcinomas in a Large Real-World Cohort.J Nicholas Bodor, Joanne Xiu, Vinicius Ernani, Supreet Kaur, Hirva Mamdani
Clinical Lung Cancer. 2024-11-01 - 1 citationsPhase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Har...J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei
Clinical Lung Cancer. 2023-11-01
Press Mentions
Lantern Pharma Reports First Quarter 2024 Financial Results and Business HighlightsMay 9th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
